The interplay between growth factors and transcription factors in vertebrate neurogenesis is poorly understood. MASH1 is a basic helix-loop-helix (bHLH) transcription factor that is essential for autonomic neurogenesis. Bone morphogenetic protein (BMP) 2, and its relative BMP4, have been shown to induce expression of MASH1 and to promote autonomic neuronal differentiation in neural crest stem cells. The relationship between expression of MASH1 and the neurogenic competence of neural crest cells has not been investigated, however.
Background
An important problem in developmental biology is to explain in terms of the actions of specific genes the progressive changes in the competence and commitment of undifferentiated progenitor cells to adopt particular fates. This problem is a challenging one, because 'competence' and 'commitment' are cellular properties that are operationally defined by transplanting or culturing cells or tissues, while gene action is defined by loss-of-function or gain-of-function mutations which are usually analyzed in the context of an intact embryo. To bridge these levels of analysis, it is necessary both to manipulate progenitor cells genetically and to challenge them by altering their environment. There are relatively few experimental systems in which such manipulations have been feasible, however.
Transcription factors in the basic helix-loop-helix (bHLH) family have been identified as key determinants of cell fate (for reviews, see [1] [2] [3] ). In Drosophila, bHLH proteins encoded by the proneural genes of the achaete-scute complex are necessary for neural cell fate determination (for review, see [4] ). Expression of achaete-scute genes in neuroectodermal cells is insufficient to commit them to a neural fate. It is thought, however, that these genes confer competence to adopt a neural fate, because in neurogenic mutants (such as Notch -), most or all cells of the proneural cluster become sensory organ precursors, and this conversion is dependent on achaete-scute function (reviewed in [5] ). In addition, commitment to a neural fate is correlated with increased levels of achaete-scute expression [6] . Whether such a quantitative increase in proneural gene expression is actually responsible for commitment, however, has not yet been established.
In mammals, forced expression of muscle-specific bHLH factors, such as MyoD, can promote myogenic differentiation in a variety of heterologous cell types (reviewed in [7] ). MyoD is therefore sufficient to confer competence for myogenesis. As in the case of achaete-scute expression and Drosophila neurogenesis, it is thought that expression of MyoD above a threshold level is required for commitment to myogenic differentiation [2] . The precise relationship between expression of myogenic bHLH genes and the state of commitment to a muscle fate is not clear, however, because of the difficulty of isolating embryonic muscle precursor cells at the time that they first express such genes.
The neural crest is a system in which multipotent progenitor cells become competent and then committed to generate one of several alternative fates. Mash1, a mammalian homolog of achaete-scute [8] , is expressed in precursors of autonomic neurons that derive from the neural crest [9] and is essential for the differentiation of these neurons [10] [11] [12] . It is not clear whether Mash1 confers competence for neurogenesis or is only required for overt differentiation. In part, this has reflected the lack of appropriate cell populations in which to perform gain-offunction manipulations for this gene [13] .
Previously, we isolated a population of post-migratory neural-crest-derived precursors of autonomic (enteric) neurons from the developing gut, using monoclonal antibodies to the receptor tyrosine kinase c-RET [14] . Most (≥ 85%) of such cells express Mash1 at the time of their isolation. Approximately 30-50% of the cells behave as committed neuronal precursors [14] ; however, the remainder divide to produce clones containing non-neuronal cells. These observations suggested that Mash1 expression is insufficient to commit neural crest cells to a neuronal fate; however, they left open the issue of whether the nonneuronal cells that express Mash1 are competent for neurogenesis or, rather, are committed to a non-neuronal fate.
We have now used BMP2, which promotes autonomic neurogenesis in cultures of premigratory neural crest stem cells (NCSCs) [15] , to challenge the non-neurogenic subpopulation of c-RET + cells and to determine whether they are competent for neurogenesis. Surprisingly, virtually all such cells are competent to differentiate into neurons when exposed to BMP2. Neurogenic competence declines with time in culture, however, and is paralleled by a gradual extinction of Mash1 expression in these cells; extinction of Mash1 expression can be prevented by maintaining the cells in BMP2. Forced expression of Mash1 from a retroviral vector prevents this progressive loss of neurogenic competence. These results suggest that Mash1 maintains competence for neurogenesis in post-migratory neural crest cells. Moreover, the data reveal an unexpected positive-feedback interaction between BMP2 and MASH1, which may underlie the progressive commitment of the progenitor cells to a neuronal fate.
Results
Non-neuronal cells expressing c-RET are capable of differentiating into smooth muscle or glia As described previously [14] , approximately 50% of c-RET + cells divide to generate clones of flat, nonneuronal cells (Fig. 1) . These clones could contain differentiated non-neuronal cell types, precursors of neurons which failed to undergo overt differentiation, or both. We therefore stained such clones with antibody markers for smooth muscle or glia, two non-neuronal cell types produced by NCSCs under similar culture conditions [15] [16] [17] . We found that 35 ± 5% (2 experiments, 85 colonies counted) of non-neuronal clones contained cells that expressed both smooth muscle actin (SMA) and calponin after 4 days in standard culture medium (Fig. 2a,b) . In separate experiments, 10 ± 2% ( 2 experiments, 121
Figure 1
Morphology of a typical non-neuronal clone in cultures of c-RET + cells. The cell was identified 15 h after plating (a), and photographs of the same field were taken every 24 h for the next 3 days (b-d). Approximately 50% of the plated cells behave in this way (see Table 1 and [14] ). All images were viewed using the 40× objective, except for (d) which was viewed using the 20× objective.
colonies examined) of the clones contained at least some GFAP + glial cells after 14 days in culture (Fig. 2c,d ). The proportion of glial or smooth-muscle cell-containing clones was not significantly increased by addition of GGF or TGF␤1, which promote glial and smooth muscle differentiation, respectively, in NCSC cultures [15, 17] (data not shown). Taken together, these data indicate that, under our standard culture conditions, at least some c-RET + non-neuronal cells can generate smooth muscle or glia.
c-RET + non-neuronal cells are competent for neuronal differentiation
The observation that the non-neurogenic subset of c-RET + cells can differentiate into smooth muscle or glial cells raised the question of whether these cells are committed to such non-neuronal fates. To address this question, we challenged the cells by exposing them to BMP2, a growth factor recently shown to promote autonomic neurogenesis by uncommitted NCSCs [15] .
In striking contrast to their behavior in control medium, in the presence of BMP2 (50 ng ml -1 ) over 80% of c-RET + cells differentiated to cells with a neuronal morphology (Fig. 3) . These cells expressed neuronal markers, such as neurofilament and peripherin, as well as the autonomic lineage marker B2 [18, 19] (data not shown). A doseresponse experiment indicated that a half-maximal effect of BMP2 was obtained at about 0.5 ng ml -1 BMP2 (Fig. 4a) . To determine whether the growth factor actually caused the conversion of non-neuronal cells to a neuronal fate, or simply supported the selective survival of neurogenic clones at the expense of non-neuronal clones, we analyzed the fates of cohorts of identified founder cells. In either the presence or absence of BMP2, less than 10% of the clones died (Fig. 4b ), yet the fraction of neuronal clones increased from less than 40% in control medium to over 90% in BMP2; concomitantly, the proportion of non-neuronal clones decreased from 50% to 10% and that of mixed clones from about 15% to 0% (Fig. 4b) . These results argue that the increase in the percentage of neuronal clones caused by BMP2 is due to the phenotypic conversion of non-neuronal (and mixed) clones to neuron-only clones. This, in turn, indicates that the subset of c-RET + cells that can generate non-neuronal derivatives (such as smooth muscle or glia) under control culture conditions is nevertheless competent to undergo neuronal differentiation if challenged with BMP2.
Competence to respond to BMP2 declines with time in vitro
The ability of c-RET + cells to differentiate into neurons when challenged with BMP2 progressively declined with time in culture. When BMP2 was added 3 hours after plating, 89 ± 5% of a cohort of identified c-RET + founder cells differentiated as neuron-only clones; by contrast, if addition of BMP2 was delayed for 47 hours, only 51 ± 5% of identified cells differentiated in this way (Table 1) . Conversely, the percentage of non-neuronal clones increased, from 8 ± 5% to 38 ± 8%. Importantly, the percentage of cells or clones that died was ≤ 5% in all conditions, indicating that delayed addition of BMP2 did not simply lead to the selective death of neurogenic cells (Table 1 ). These data suggest that the subset of c-RET +
Figure 4
Dose-dependence and instructive nature of the BMP2 effect. (a) At each of the indicated concentrations of BMP2, a cohort of clones was identified at the beginning of the experiment and the presence of neurons determined after a 4 day incubation (shaded bars). In a separate experiment, the proportion of clones containing any MASH1 + cells was determined by immunostaining after 67 h (white bars). The values represent the mean ± S.D. of duplicate plates from two independent experiments. The total number of colonies (from two separate experiments) examined at each concentration of BMP2 averaged 117 (range 73-167) for MASH1 expression, and 222 (range 139-344) for neuronal differentiation. (b) Clonal analysis. A cohort of founder cells was identified before addition of BMP2 (50 ng ml -1 ) 3 h after plating and the fate of the colonies determined after a 4 day incubation: 'neuronal' clones consisted purely of neurons; 'mixed' clones consisted of both neurons and non-neuronal cells; 'non-neuronal' clones consisted only of non-neuronal cells; and 'dead,' clones died (usually within the first 24 h of the incubation). The increase in the proportion of neuron-only clones in BMP2 (neuronal, compare the light and dark shaded bars) and the concomitant decrease in the proportion of non-neuronal clones, with a small and unchanging proportion of dead clones, suggests that BMP2 converts non-neuronal to neuronal clones. In two independent experiments, a total of 201 colonies were scored in the control condition and 198 colonies in BMP2. Values represent the mean ± range from the two experiments. Table 1 Responsiveness to BMP2 declines with time in clonal culture.
Clone composition BMP2 Neuronal Mixed Non-neuronal Dead n addition None 37 ± 4% 12 ± 1% 48 ± 1% 5 ± 4% 201 3 h 89 ± 5% 0% 8 ± 5% 3 ± 0% 198 17 h 85 ± 6% 1 ± 1% 13 ± 3% 2 ± 2% 177 47 h 51 ± 5% 9 ± 1% 38 ± 8% 3 ± 3% 191 E14.5 c-RET + cells were plated at colony density (300 cells per 35 mm dish) and a cohort of founder cells were identified and circled 17 h after plating. 'BMP2 addition' indicates that BMP2 (50 ng ml -1 ) was added at the indicated times, or not at all ('None'). At the end of a 4 day incubation, colonies were scored as containing only neurons (neuronal), only non-neuronal cells (non-neuronal), a mixture of neurons plus non-neuronal cells (mixed), or 'dead' (if the cells in the colony died during the incubation; such death usually occurred within the first 24 h after circling). The data represent the mean of two different experiments, with duplicate dishes for each condition within each experiment; n indicates the total number of clones analyzed for each time point. The number of dead clones is small and invariant, implying a time-dependent change in the interconvertibility of non-neuronal clones to neuronal clones in response to BMP2.
cells that are not already committed to a neuronal fate lose neurogenic capacity with time in culture. The proportion of mixed colonies (neuronal plus non-neuronal cells) also increased when presentation of BMP2 was delayed (Table 1 , 'mixed'), further suggesting that neurogenic potential is not always lost in a clonal or synchronous manner.
Loss of neurogenic competence is paralleled by a decline in MASH1 expression in non-neuronal cells
We next sought to understand in molecular terms why most c-RET + cells are initially competent for neurogenic differentiation but progressively lose this capacity with time in culture. Previously, we noted that approximately 85% of freshly isolated c-RET + cells express detectable levels of MASH1, although the level of expression varies from cell to cell [14] . The proportion of c-RET + cells that differentiate into neurons in response to an early addition of BMP2 (about 85-89%; Fig. 4 and Table 1 ) is similar to the proportion of freshly-isolated cells that are MASH1 + , suggesting that expression of MASH1 may correlate with competence to respond to BMP2. Moreover, in the absence of BMP2, the proportion of non-neuronal cells that express MASH1 declines: by 67 h in vitro, only 41 ± 10% (3 experiments, 168 colonies examined) of flat cells expressed detectable levels of MASH1. These data suggest that the decline in neurogenic capacity is reflected in a gradual extinction of MASH1 expression. As described below, functional perturbation experiments suggest that maintenance of MASH1 expression by these cells is causally related to maintenance of competence for neuronal differentiation.
BMP2 maintains expression of MASH1 in vitro
The fact that BMP2 induces de novo expression of MASH1 in NCSCs [15] suggested that this growth factor might also maintain expression of MASH1 in the c-RET + population. To address this issue, cells were cultured for 67 hours in varying concentrations of BMP2, and then fixed and stained with anti-MASH1 antibody. In the absence of BMP2, 59 ± 10% of non-neuronal clones were MASH1 -at 67 hours (Fig. 5a,b) , whereas in the presence of BMP2, 80-90% of these clones contained at least some MASH1-expressing cells (Fig. 5c,d) . A dose-response experiment indicated that the concentrations of BMP2 which allowed maintenance of MASH1 expression were similar to, but slightly lower than, those required for induction of neuronal differentiation (Fig. 4a, white bars) . Taken together, these results suggested that the ability of BMP2 to promote neuronal differentiation in c-RET + cells is reflected in its ability to maintain MASH1 expression in these cells.
Constitutive expression of MASH1 maintains competence to respond to BMP2
We next examined whether constitutive expression of MASH1 from a retroviral vector in embryonic day 14.5 (E14.5) c-RET + cells maintained competence for neurogenesis in response to a delayed presentation of BMP2. Sequences encoding a Myc-epitope tag [20] were incorporated into the Mash1 transgene to distinguish the product from endogenous MASH1. As a control, cells were infected with a retrovirus encoding epitope-tagged E12, a ubiquitously expressed bHLH protein [21] that heterodimerizes with MASH1 [22] and other tissue-specific . 4a ), although the level of expression varied from cell to cell. All images were viewed using the 40× objective.
bHLH proteins, such as MyoD [23] , as well as with inhibitory HLH proteins such as Id [24] . Following infection, the cells were replated at clonal density to permit identification of the non-neuronal subset. Approximately 2 days later (by which time most, or all, committed neuronal precursors had already differentiated and could therefore be excluded by their process-bearing morphology), a cohort of non-neuronal colonies was identified and circled. BMP2 was then added to some of the cultures. After a further 2 day incubation, the cultures were fixed and double-labeled for the 160 kDa neurofilament protein (NF160) to reveal neuronal clones and for the Mycepitope tag (to reveal retrovirally infected colonies; Fig. 6 ).
In some experiments, peripherin was used as an alternative neuronal marker.
Cells expressing exogenous MASH1 showed a higher likelihood of neuronal differentiation than control cells when BMP2 was added after 67 hours in culture: 74 ± 8% (92 colonies examined) of Myc-tag-positive colonies in Mash1-retrovirus-infected cultures contained at least some neurons; 58% of all Myc-tag-positive clones consisted purely of neurons (Table 2 and Fig. 7a-c) . These neuronal cells expressed other markers, such as peripherin, in addition to neurofilament (not shown). By contrast, only about 27% of uninfected (Myc-tag-negative) clones in the same cultures contained some neurons, and only 14% contained exclusively neurons (Table 2 ). In E12-infected cultures exposed to late addition of BMP2, only 34% of the Myctag-positive clones contained some neurons, and only 24% contained exclusively neurons. Almost 70% of the E12-expressing clones contained only non-neuronal cells (Fig.  7d-f and Table 2 ). Furthermore, the proportion of neuronal colonies in these E12-infected cultures was the same whether the clones were Myc-tag-positive (infected) or Myc-tag-negative (uninfected; see Table 2 ). That E12 had no effect suggests that the effect of MASH1 reflects its specific transcriptional activation function [22] , and not simply a sequestering of negative regulators [24] . Taken together, these data suggest that constitutive expression of MASH1 can maintain competence to differentiate to neurons in response to BMP2. In the absence of BMP2, however, expression of exogenous MASH1 was insufficient to promote neuronal differentiation ( Table 2) .
Discussion
In this paper we have investigated the relationship between expression of MASH1, a bHLH transcription factor essential for autonomic neurogenesis [25] , and the developmental potential of an isolated population of postmigratory neural crest cells [14] . Our results indicate that there is a correlation between expression of MASH1 and competence for neuronal differentiation elicited by exposure to BMP2. Expression of MASH1 declines with time but can be maintained by continuous exposure to BMP2. Competence for neuronal differentiation elicited by BMP2 also declines with time but can be maintained by constitutive expression of MASH1 from a retroviral vector. These results suggest a self-reinforcing positive-feedback interaction between the expression of MASH1 and the action of BMP2, which may underlie progressive commitment to neurogenesis (Fig. 8) . In the absence of BMP2, c-RET + cells can differentiate to non-neuronal fates, such as smooth muscle and glia. Thus, BMP2 appears to maintain a critical period for autonomic neuronal differentiation in neural crest cells as they migrate through the gut. Such a mechanism may be important in maintaining the protracted period of neurogenesis that occurs within this tissue in vivo [26] .
Figure 6
Schematic illustration of the design of the retroviral infection experiment; see text and Materials and methods section for details. Approximately 20% of the cells were infected with the retrovirus (illustrated by shading), but these were identified retrospectively by staining with an antibody to the Myc tag. Non-neuronal clones cannot be prospectively identified at the time of infection, but by 43 h after replating at clonal density, cells which will generate neurons have done so and can be excluded from further analysis by morphological criteria. At this time, cohorts of nonneuronal clones were identified and circled, BMP2 added to some, and the fate of these clones determined after a further 2 day incubation. Table 2 Forced expression of Mash1 in non-neuronal precursors maintains competence for neuronal differentiation in response to BMP2. In other experiments, such neuronal colonies also expressed other markers such as peripherin (not shown). Approximately 60% of the colonies in the experiment behaved in this way (Table 2 ). Only 14% of uninfected (Myctag-negative) colonies in the same dish behaved this way (Table 2 ; not illustrated).
Mash1-infected E12-infected

(d-f)
A clone from an E12-infected culture grown in BMP2. The E12-expressing cells are identified by nuclear (and some cytoplasmic) staining with the anti-Myc-tag antibody (e), have a non-neuronal morphology (d) and do not express neurofilament (f). Approximately 66% of the colonies in the experiment behaved in this way ( Table 2 ). Note that no neuron-containing colonies were observed in either the Mash1-or E12-expressing colonies grown in the absence of BMP2 ( Table 2 ). All images were viewed using the 40× objective.
E14.5 c-RET + cells were plated and analyzed according to the experimental design schematically illustrated in Fig. 6 . Briefly, the cells were plated at high density for 15 h and then infected with Mash1-or E12-encoding retrovirus (see Materials and methods section) in three successive rounds. The cells were replated at 300 cells per 35 mm dish; 43 h later, non-neuronal colonies were identified and circled and BMP2 (50 ng ml -1 ) added to some dishes. After a further 2 day incubation, the cultures were fixed and double-labeled with antibodies to the Myc epitope tag and to neurofilament (see Fig. 7 ). In each plate, 20-30 identified colonies were characterized as either uninfected or infected (Myc: -or +, respectively), and as containing neurons or only non-neuronal cells. Neuron-containing colonies were further subdivided into neuronal only or mixed neuronal plus non-neuronal colonies. Numbers represent the mean ± S.D. from the indicated numbers of colonies in a single representative experiment. The experiment was repeated twice with similar results. Note that the proportion of neuron-containing colonies in BMP2 is much higher (74%) in MASH1-infected cells than in either uninfected cells in the same plates (26%) or E12-infected colonies in separate plates (34%).
Function of MASH1 in c-RET + cells
The fact that most or all c-RET + cells initially express MASH1, yet they can generate smooth muscle or glia, indicates that expression of MASH1 is by itself insufficient to commit the cells irreversibly to a neuronal fate. However, expression of MASH1 appears to underlie competence to differentiate to neurons in response to BMP2. Interestingly, forced expression of Mash1 in nonneuronal cells did not promote neurogenesis on its own; rather, it simply maintained responsiveness to BMP2. In the context of c-RET + cells, therefore, Mash1 behaves like a true determination gene: it confers or maintains competence to differentiate in a particular direction, but this competence is a latent state that can only be revealed by exposure of the cells to appropriate inducing signals.
The ability of Mash1 to confer or maintain the neurogenic competence of progenitor cells is reminiscent of the function of its homologs, the proneural genes of the achaete-scute complex, in Drosophila. The initial expression of achaete-scute occurs in a cluster of neuroectodermal cells and is thought to confer on these cells competence for neural differentiation. Subsequently, one of the cells in this 'proneural' cluster achieves a higher level of proneural gene expression than its neighbors, delaminates and becomes a sensory organ precursor (for review, see [27] ). Thus, in the fly, as in mammals, expression of achaetescute/Mash1 alone is insufficient to commit cells to a neural or neuronal fate; rather, it renders the cells competent to express this fate in response to subsequent events.
In Drosophila, loss-of-function mutations in achaete-scute revealed that these proneural genes are essential for formation of the sensory organ precursor [28] , but did not address the issue of competence. Evidence for a function in promoting competence was established by mis-expression of achaete-scute in the neurectoderm, which causes the appearance of ectopic sensory bristles [29] . Similarly, analysis of Mash1 -/-mutant mice has revealed an essential function for this gene in autonomic neurogenesis [11, 25] , but did not exclude a function in conferring competence to adopt a neuronal fate. The results presented here represent the first gain-of-function data for Mash1. The detection of a Mash1 gain-of-function phenotype stands in contrast to previous experiments in cell lines [8, 13] , and may reflect our use of primary progenitor cells derived from a lineage in which the gene is normally expressed. Similarly, in Drosophila, the ability of achaete-scute to promote ectopic sensory bristle formation occurs only within highly restricted spatial and temporal domains within the neurectoderm [29] .
Earlier analysis of Mash1 -/-mutants suggested that the gene is required in autonomic neurogenesis only after precursors are already committed to a neuronal fate and express markers such as neurofilament and neuron-specific ␤-tubulin [11] . However, MASH1 protein is clearly produced in progenitor cells that have not yet expressed such neuronal genes, and which are not committed to a neuronal fate ( [14] and this study). The present data suggest that the expression of MASH1 in these cells may confer competence for neuronal differentiation. If so, then MASH1 would act at several successive stages in neurogenesis within the autonomic lineage. The failure to observe an essential function for Mash1 at the earlier developmental stage in the null mutant may reflect the existence of functionally redundant genes or other compensatory mechanisms. Similarly, in Drosophila the loss-of-function phenotype of achaete-scute is detected as a failure to produce sensory organ precursor cells [28] , even though
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Figure 8
Proposed roles of BMP2 and MASH1 in progressive commitment of neural crest cells to an autonomic neuronal fate. Naive neural crest stem cells do not initially express MASH1, but the transcription factor is induced in these cells by BMP2 [15] . BMP2 is required to maintain (and possibly increase) expression of MASH1 in c-RET + cells. MASH1, in turn, feeds back to maintain or enhance responsiveness to BMP2. Eventually, the cells commit to a neuronal fate and differentiate to neurons in the absence of exogenous BMP2, in a manner that cannot be inhibited by GGF [14] or TGF␤1 (L.L. and D.J.A., unpublished observations); c-RET + cells cultured in the absence of BMP2 eventually lose MASH1 expression and neurogenic capacity, and differentiate to glia, smooth muscle or other unidentified nonneuronal cell types. Delayed addition of BMP2 can rescue some of these cells and divert them back to a neuronal fate, but this rescuability declines with time (dashed arrows) and can be maintained by forced expression of MASH1. the gene is also believed to function earlier, in conferring neural competence on cells of the proneural cluster [30] . Although we cannot exclude the possibility that the function for Mash1 revealed here is an artifact of overexpressing the gene, we feel this is unlikely given the correlation between the expression of endogenous Mash1 and competence for neurogenesis elicited by BMP2. Rather, our results underscore the need for both loss-of-function and gain-of-function data in understanding the developmental function(s) of a regulatory gene [5] .
An unanswered question concerns the relationship between Mash1 expression and differentiation to smooth muscle and glial fates. Initial expression of Mash1 in c-RET + cells does not preclude eventual differentiation of some cells to these non-neuronal fates. However, the proportion of smooth muscle and glia was not increased by TGF␤1 or GGF2, respectively, growth factors which promote these lineages in NCSC cultures [15, 17] . The reason for the lack of responsiveness to these factors in the post-migratory c-RET + population is not clear. Although it could be related to the expression of Mash1, responsiveness to TGF␤1 and GGF2 was not recovered during the culture period when Mash1 is down-regulated (L.L. and D.J.A., unpublished observations). It was therefore not possible to test in this system whether forced expression of Mash1 would inhibit responsiveness to TGF␤1 or GGF2. We are currently examining this issue in cultures of NCSCs.
Developmental potential and lineage relationships of c-RET + neural crest cells
Previously, we found that the c-RET + population contains a mixture of precursors committed to a neuronal fate, and other precursors fated to generate non-neuronal cells under the same conditions in vitro [14] . Here, we have shown that these non-neuronal derivatives include smooth muscle and glia, derivatives which are also produced by more primitive neural crest stem cells under the same culture conditions [15, 16] . These observations raised the possibility that the c-RET + population, though antigenically homogeneous, comprises a mixture of progenitors committed to either neuronal or non-neuronal fates. But, in fact, our results indicate that virtually all c-RET + cells can adopt a neuronal fate in the presence of BMP2. The antigenic homogeneity of the isolated population therefore reflects an underlying homogeneity in developmental potential. The heterogeneity in overt neuronal differentiation observed within the c-RET + population, when cultured without BMP2, may simply reflect asynchrony in the extent of irreversible commitment to neurogenesis among individual cells at the time of isolation. Such asynchrony could reflect the extended period over which neurogenesis normally occurs in the fetal gut [26] .
Our results do not address the question of whether all c-RET + cells are normally fated to generate neurons in vivo, or rather generate a mixture of neuronal and nonneuronal derivatives as they do in vitro. The data suggest that the actual fate of c-RET + cells in vivo may simply depend on whether they are exposed to BMP2 (or BMP4) for a sufficient period of time. Our observations also underscore the danger in inferring the extent of commitment of neural crest cells simply on the basis of their clonal fates in vitro, without challenging the cells by exposure to factors that promote alternative fates. Even under 'permissive' conditions, cells may possess developmental capacities that they do not reveal because of variations in local microenvironment, stochastic events, or other uncontrolled variables.
A feedback interaction loop between BMP2 and MASH1
Our experiments point to an unexpected feedback interaction between MASH1 and BMP2. The present and previous work [15] , taken together, indicate that BMP2 is required for both induction and maintenance of Mash1 expression. In turn, continued expression of Mash1 in progenitor cells maintains their capacity to respond to BMP2. Thus, the growth factor and transcription factor interact in a reciprocal manner to promote neurogenesis. BMP2 induces Mash1; MASH1 in turn maintains or enhances responsiveness to BMP2; and BMP2 further promotes continued expression of Mash1. In this way, BMP2 maintains competence to respond to itself, and MASH1 helps to sustain its own expression by maintaining responsiveness to BMP2. This linkage creates a self-reinforcing positive-feedback loop that may help to drive the cells to a neuronal fate (Fig. 8) . If the cells are cultured on their own until Mash1 expression declines, however, subsequent addition of BMP2 is unable to promote neurogenesis (Fig. 8, dashed arrows) . This suggests that, if the BMP2-MASH1 feedback loop is not maintained, an apparently irreversible loss of neurogenic potential occurs. The basis for this irreversible change is not understood.
Previous studies of bHLH gene regulation and function have emphasized the importance of autoregulatory loops [1, 2] . In the case of achaete-scute and MyoD, these loops are assumed to be implemented by binding of the transcription factors to their own promoters [31] [32] [33] . Here, we provide evidence for a positive-feedback loop in which MASH1 indirectly reinforces its own expression by promoting responsiveness to BMP2, a growth factor that in turn induces and maintains expression of Mash1. The incorporation of such an extracellular signal in a transcription factor 'autoregulatory' loop would allow for greater flexibility and amplification capacity in the control of such a feedback circuit, and may prove to be a common mechanism of cell fate determination in many systems.
Conclusion
The results described here suggest that the bHLH transcription factor MASH1 may play at least two sequential roles during neurogenesis: it may confer or maintain the competence to adopt a neuronal fate in uncommitted cells, in response to signals such as BMP2; and it is essential for the execution of neuronal differentiation in precursors that are probably committed to this fate. In addition, the progressive commitment of neural crest cells to neurogenesis may involve a positive feedback interaction between MASH1 and BMP2, in which the transcription factor maintains responsiveness to the growth factor, which in turn promotes expression of the transcription factor. This type of reciprocal interplay between cell-intrinsic and cell-extrinsic factors seems likely to be a general feature of lineage commitment in many systems.
Materials and methods
Culture of c-RET + cells
c-RET + primary rat enteric precursor cells were isolated and cultured in standard medium [16] as described [14] . Recombinant human BMP2 was a gift from Genetics Institute. Recombinant human TGF-␤1 was purchased from R&D Systems. Recombinant human GGF was a gift from Cambridge Neurosciences [17] .
Immunocytochemistry
Monoclonal antibodies to MASH1 [9] , GFAP (Sigma), NF160 (Sigma), ␣ smooth muscle actin (Sigma), and calponin (Sigma) were used as described [11, 15, 17] . Detailed immunostaining protocols are available on request. Expression of smooth muscle markers was apparent after 4 days, whereas that of GFAP was not detected until after 14 days, the usual incubation period required to observe GFAP expression in NCSCs [17] . Because of the different incubation periods and staining protocols employed, we did not examine the overlap between glial and smooth muscle fates in these experiments. Hybridoma cells producing monoclonal antibodies to the human c-Myc epitope (clone Myc 1-9E10.2) were obtained from the ATCC. Cultures were incubated for 18 h at 4°C in anti-Myc-tag hybridoma supernatant diluted 1:1 with standard culture medium, followed by a horse radish peroxidase-conjugated goat anti-mouse IgG (Chemicon).
Construction of pBABE retroviral vectors
Vector constructions were performed using standard molecular cloning techniques. Mash1 and E12 cDNAs were cloned in-frame with an amino-terminal Myc-epitope tag into a novel retroviral vector called pBabeMT.APPuro. This vector is a modification of the pBabe puro vector described in [34] , in which the selectable marker (puromycin resistance) is under the control of an internal SV40 promoter-enhancer, and the foreign coding sequences are under control of the viral LTR. This plasmid was modified to contain an internal ribosome entry site (IRES)-human placental alkaline phosphatase cassette downstream of the cloning site, and a Myc-epitope tag (derived from the plasmid pCS2+MT [35] ) upstream of it. This vector allows immunodetection of virally infected cells using antibodies either to alkaline phosphatase, which is expressed on the cell surface, or to the Mycepitope tag which is fused in-frame to the gene of interest. A detailed restriction map for this vector is available upon request. Viral supernatants for infection were produced by transient transfection in BOSC-23 cells as described [36] .
Retroviral infection of c-RET + cells
Examination of the effect of constitutive expression of Mash1 from a retroviral vector on the neurogenic capacity of the non-neuronal subset of c-RET + cells was complicated by a number of factors: firstly, only a fraction of the cells (10-20%) exposed to the recombinant retrovirus are infected, and it could not be prospectively determined which cells were infected; secondly the non-neurogenic population represents a subset (about 50%) of the c-RET + cells and these cannot be prospectively identified (that is, distinguished from the subset already committed to differentiate to neurons) at the time of retroviral infection. We therefore adopted a strategy in which retroviral infection was followed by analysis at clonal density (see Fig. 6 ), and retrospective identification of virally-infected cells using antibody to the Myc-epitope tag incorporated into the heterologous gene (Mash1 or E12). This experimental design incorporates two types of control: an internal control, in which the proportion of neuronal colonies is compared between infected and uninfected colonies in the same plate, and an external control in which the proportion of neuronal colonies is compared between Myc-tag + cells in Mash1-infected and E12-infected cultures.
Approximately 5 000 freshly isolated E14.5 RET + enteric cells were plated on a poly-D-lysine/fibronectin substrate [16] in a glass cloning cylinder (3 mm inner diameter) located in the center of a 35 mm dish.
The cloning cylinder and medium were removed after an overnight incubation and Mash1-or E12-expressing retroviral supernatants were diluted 1:1 with standard medium (SM) [16] and added to the cells. After a 3 h incubation at 37°C, the viral solution was removed and the culture was washed once with fresh SM. Cells were allowed to recover in SM for 1 h and the infection procedure repeated for two more rounds. Following infection, cells were washed three times with SM and removed from the dishes with a 0.05% trypsin solution (GIBCO/BRL). The cells were counted and replated at 300 cells per 35 mm dish on poly-D-lysine/fibronectin. Approximately 2 days after replating, most neuron-containing clones had already differentiated and could therefore be identified and excluded by their process-bearing morphology. A cohort of non-neuronal colonies was then identified and circled; such colonies never differentiated into neurons if the incubation was continued for 2 more days in the absence of BMP2 (Table 2) . BMP2 (50 ng ml -1 ) was added to some of the cultures. After 2 more days of incubation, the cells were fixed and stained for the Myc-epitope tag to reveal the expression of Mash1 or E12 transgenes and counterstained with anti-NF160 to reveal the presence of neurons.
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